Who owns the UCIVIDY trademark?

The UCIVIDY trademark is owned by Athira Pharma, Inc..

What class is the UCIVIDY trademark registered in?

The UCIVIDY trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for UCIVIDY?

The USPTO serial number for UCIVIDY is 97860535.

What is the registration number for UCIVIDY?

UCIVIDY is registered under USPTO registration number 0.

Sealvo

Home Search: UCIVIDYUCIVIDY #97860535

Back

Updated Oct 10, 2026·8 searches this week

View on USPTO TSDR Find similar marks

UCI

USPTO Trademark Record

ABANDONED

UCIVIDY

SN 97860535·Reg 0·Filed Mar 28, 2023

Owner Athira Pharma, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

UCIVIDY (Serial No. 97860535), Registration No. 0, is a abandoned US trademark filed on Mar 28, 2023 by Athira Pharma, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

UCIVIDY (Reg. #0) is an abandoned US trademark that was filed in 2023 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 28, 2023

SERIAL

97860535

REG#

Filing Information

StatusABANDONED

Filing DateMar 28, 2023

Serial Number97860535

Registration No.0

Status DateJan 05, 2026

Published for OppositionApr 08, 2025

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1756378

499Sep 22, 2023

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

26 events

ABANDONMENT - NO USE STATEMENT FILED

Jan 05, 2026

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Jan 05, 2026

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 03, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 08, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 08, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 02, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 11, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Mar 03, 2025

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 03, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 03, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

FINAL REFUSAL WRITTEN

Dec 04, 2024

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Dec 04, 2024

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Dec 04, 2024

NOTIFICATION OF FINAL REFUSAL EMAILED

ASSIGNED TO EXAMINER

Oct 25, 2024

ASSIGNED TO EXAMINER

Jul 16, 2024

ASSIGNED TO EXAMINER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 15, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 15, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 15, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jan 26, 2024

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jan 26, 2024

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION WRITTEN

Jan 18, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jan 18, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 18, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 21, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 04, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 31, 2023

NEW APPLICATION ENTERED

Other Marks by Athira Pharma, Inc.

Additional USPTO filings from the same owner.

JOI

JOIMEMVI

97860538

Athira Pharma, Inc.

ABANDONED

EUP

EUPAVIDY

97860520

Athira Pharma, Inc.

ABANDONED

JOF

JOFILNY

97860514

Athira Pharma, Inc.

ABANDONED

Other Marks by Kevin S. Costanza

Additional USPTO filings handled by the same attorney of record.

BDA

99080927

REGISTERED

LOG

LogoMark

98928267

99078561

ECO-LOK

88265520

REGISTERED

UCIVIDY

Run a conflict check

Other Marks by Athira Pharma, Inc.

Other Marks by Kevin S. Costanza

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company